Accelerbiotics® develops affordable high-throughput sustainable solutions for biotechnology and life science field:
Our technologies addresse the huge bottlenecks of low throughput and the high cost associated with several essential applications.
Accelerbiotics® is pioneer in providing low-cost high-throughput solutions that accelerate performance and development in areas of biotech academia research, biotech industry and life science.
June/2020: Accelerbiotics® receives the Innobooster Additional Grant During COVID-19 from Innovations Fund Denmark (Innovationsfonden): We are so grateful to Innovations Fund Denmark for giving us this additional grant. With this additional support, we will streamline our MVPs products for extraction and analysis of nucleic acid (RNA) from coronavirus and other future pandemics, and subsequently bring our products to CE marking. This below video illustrates our workflow for accurate COVID-19 diagnosis and other future pandemics:
April/2020: Accelerbiotics® provides affordable high-throughput solutions that can significantly accelerate diagnosis of COVID-19 and other future pandemics:
The coronavirus (COVID-19) pandemic is spreading exponentially across the world, while there is shortage and lack of of equipment, kits and high-throughput fast solutions for accurate diagnosis of COVID-19. Hereby, Accelerbiotics provides affordable high-throughput solutions for screening and analysis for samples of coronavirus (COVID-19). Accelerbiotics is currently open for collaborations and partnerships, investments and funding, support from both governmental and private sector in order to kick off professional manufacturing on production level for devices that can accelerate significantly diagnosis of COVID-19. Please, see below more information about this:
Copyright © All Rights Reserved